Recent studies suggest an association between statin use and a reduced risk of prostate cancer. Statin-induced apoptosis and antitumor activity have been demonstrated in prostatic cancer cell lines in vitro. However, little data exists on histological effects in patients with prostate cancer. Our aim was to evaluate whether patients who reported a history of statin use presented with more favorable pathologic features of prostate cancer than those who did not receive statins.